CME Group (NASDAQ:CME) had its price objective decreased by investment analysts at JPMorgan Chase & Co. from $183.00 to $173.00 in a research report issued on Friday, The Fly reports. The brokerage currently has an “underweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 16.00% from the company’s current price.

A number of other equities analysts also recently commented on CME. Berenberg Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $236.00 to $227.00 in a research note on Thursday, September 19th. Oppenheimer began coverage on CME Group in a research report on Monday, September 16th. They set an “outperform” rating and a $234.00 target price on the stock. Citigroup increased their target price on CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a research report on Monday, October 21st. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Finally, ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. CME Group has an average rating of “Hold” and a consensus target price of $205.62.

NASDAQ:CME opened at $205.96 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91. The company has a 50-day moving average of $203.69 and a 200 day moving average of $204.99. The firm has a market cap of $74.34 billion, a PE ratio of 29.42, a price-to-earnings-growth ratio of 4.09 and a beta of 0.17.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the firm posted $1.45 EPS. The company’s revenue for the quarter was up 41.3% on a year-over-year basis. Sell-side analysts anticipate that CME Group will post 6.88 EPS for the current fiscal year.

In other news, Director Ronald A. Pankau sold 300 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $199.02, for a total value of $59,706.00. Following the completion of the sale, the director now owns 3,906 shares of the company’s stock, valued at approximately $777,372.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.20% of the company’s stock.

A number of large investors have recently made changes to their positions in CME. Buckingham Asset Management LLC increased its stake in CME Group by 1.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock valued at $700,000 after purchasing an additional 49 shares in the last quarter. IHT Wealth Management LLC grew its holdings in shares of CME Group by 1.1% during the second quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock valued at $855,000 after buying an additional 50 shares during the last quarter. Covington Capital Management increased its position in shares of CME Group by 2.5% in the 3rd quarter. Covington Capital Management now owns 2,050 shares of the financial services provider’s stock valued at $433,000 after acquiring an additional 50 shares during the period. Pitcairn Co. increased its position in shares of CME Group by 2.3% in the 2nd quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock valued at $435,000 after acquiring an additional 51 shares during the period. Finally, Cetera Investment Advisers increased its position in shares of CME Group by 3.4% in the 3rd quarter. Cetera Investment Advisers now owns 1,668 shares of the financial services provider’s stock valued at $351,000 after acquiring an additional 55 shares during the period. 84.27% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: What Are Cryptocurrencies?

The Fly

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.